Last Updated On 4/11/2025 1:19:33 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: TM Isotope Technologies Munich SE |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Ipsen |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Curium Pharma |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| No Relationships to Disclose |
|
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| Company: The North American Neuroendocrine Tumor Society (NANETS) |
| Recipient: You |
| Company: National Comprehensive Cancer Network® (NCCN®) |
| Recipient: You |
| Company: Healing NET Foundation |
| Recipient: You |
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|